Genzyme News
Most Popular Genzyme Story
Icahn pledges to fix what's broken at Genzyme
Carl Icahn says he's going to fix Genzyme--if other shareholders give him a chance. In his first public statement after notifying the company that he intends to fight for four seats on its board,... Read more...
Latest Headlines
- March 12, 2010
- February 24, 2010
- February 22, 2010
- February 18, 2010
- February 16, 2010
- January 29, 2010
- January 22, 2010
- January 19, 2010
- January 14, 2010
- January 8, 2010
- January 5, 2010
- December 18, 2009
- November 20, 2009
- November 17, 2009
- November 16, 2009
- September 24, 2009
- September 2, 2009
- September 1, 2009
- August 31, 2009
- August 28, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
